Back to trial
Eligibility Pre-Screening
The Butterfly study. A trial assessing acceptability and safety of using a subcutanous catheter to administer enoxaparin (Clexane) in patients requiring long-term therapy for treatment or prevention of blood clots.
This is a simplified pre-screening tool. Your answers help estimate whether you might qualify, but only the research team can confirm your eligibility. This is not medical advice.
No screening questionnaire available for this trial.